These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24803200)

  • 1. In vitro studies of epithelium-associated crystallization caused by uropathogens during urinary calculi development.
    Torzewska A; Budzyńska A; Białczak-Kokot M; Różalski A
    Microb Pathog; 2014; 71-72():25-31. PubMed ID: 24803200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of various uropathogens on crystallization of urine mineral components caused by Proteus mirabilis.
    Torzewska A; Bednarska K; Różalski A
    Res Microbiol; 2019 Mar; 170(2):80-85. PubMed ID: 30521846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.
    Torzewska A; Różalski A
    APMIS; 2014 Jun; 122(6):505-11. PubMed ID: 24164670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially Probiotic Lactobacillus Strains Derived from Food Intensify Crystallization Caused by Proteus mirabilis in Urine.
    Torzewska A; Wiewiura P; Brodecka D; Szczerbiec D; Różalski A
    Probiotics Antimicrob Proteins; 2021 Apr; 13(2):441-452. PubMed ID: 32754854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A; Rozalski A
    Microbiol Res; 2014; 169(7-8):579-84. PubMed ID: 24239192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of microbial spectrum and antibiotic resistance of uropathogens isolated from patients with urinary stones.
    Chen D; Zhang Y; Huang J; Liang X; Zeng T; Lan C; Duan X; Zhao Z; Zeng G; Tiselius HG; Lu X; Wu W
    Int J Clin Pract; 2018 Jun; 72(6):e13205. PubMed ID: 29790623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urease. The primary cause of infection-induced urinary stones.
    Griffith DP; Musher DM; Itin C
    Invest Urol; 1976 Mar; 13(5):346-50. PubMed ID: 815197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various intensity of Proteus mirabilis-induced crystallization resulting from the changes in the mineral composition of urine.
    Torzewska A; Różalski A
    Acta Biochim Pol; 2015; 62(1):127-32. PubMed ID: 25654361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary tract infection associated with urinary calculi. 1. The significance of urinary tract infection in urinary calculi].
    Takeuchi H; Okada Y; Yoshida O; Arai Y; Tomoyoshi T
    Hinyokika Kiyo; 1989 May; 35(5):749-54. PubMed ID: 2801372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary calculi and urinary tract infection. A clinical and microbiological study.
    Holmgren K
    Scand J Urol Nephrol Suppl; 1986; 98():1-71. PubMed ID: 3026032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental bladder stone production by human uropathogenic bacteria].
    Arai Y; Takeuchi H; Tomoyoshi T
    Hinyokika Kiyo; 1997 Mar; 43(3):207-11. PubMed ID: 9127756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of polymerase chain reaction to detect Proteus mirabilis and Ureaplasma urealyticum in urinary calculi.
    Huang HS; Chen J; Teng LJ; Lai MK
    J Formos Med Assoc; 1999 Dec; 98(12):844-50. PubMed ID: 10634025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Biofilm Induced Urinary Infection Stone Formation in a Novel Laboratory Model System.
    Hobbs T; Schultz LN; Lauchnor EG; Gerlach R; Lange D
    J Urol; 2018 Jan; 199(1):178-185. PubMed ID: 28827106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial properties and urease suppression ability of Lactobacillus inhibit the development of infectious urinary stones caused by Proteus mirabilis.
    Szczerbiec D; Bednarska-Szczepaniak K; Torzewska A
    Sci Rep; 2024 Jan; 14(1):943. PubMed ID: 38200115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three techniques for the diagnosis of urinary tract infections in dogs with urolithiasis.
    Gatoria IS; Saini NS; Rai TS; Dwivedi PN
    J Small Anim Pract; 2006 Dec; 47(12):727-32. PubMed ID: 17201824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi.
    Dumanski AJ; Hedelin H; Edin-Liljegren A; Beauchemin D; McLean RJ
    Infect Immun; 1994 Jul; 62(7):2998-3003. PubMed ID: 8005688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture.
    Hokama S; Toma C; Jahana M; Iwanaga M; Morozumi M; Hatano T; Ogawa Y
    Mol Urol; 2000; 4(4):321-8. PubMed ID: 11156698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done.
    Stickler DJ
    J Intern Med; 2014 Aug; 276(2):120-9. PubMed ID: 24635559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.